Literature DB >> 9932868

Demyelination and remyelination of the caudal cerebellar peduncle of adult rats following stereotaxic injections of lysolecithin, ethidium bromide, and complement/anti-galactocerebroside: a comparative study.

R H Woodruff1, R J Franklin.   

Abstract

Experimentally induced demyelination due to the direct injection of gliotoxic agents has provided powerful models for studying the biology of remyelination. For the most part, these models have involved injection into white matter tracts of the spinal cord. However, the spinal cord has a number of limitations, such as the size of lesions that it is possible to make and its unsuitability for long-term direct cannulation for the delivery of putative remyelination-enhancing agents. In this study, we describe the natural history of three new models of demyelination/remyelination based on the stereotaxic injection of three gliotoxins: lysolecithin, ethidium bromide, and a combination of anti-galactocerebroside antibody and complement (GalC-ab/comp) into the caudal cerebellar peduncle of adult rats. All three agents produced large areas of demyelination with minimal axonal damage, which undergo extensive remyelination. Ethidium bromide- and GalC-ab/comp-induced lesions remyelinated more slowly than those induced by lysolecithin. The contribution to the remyelination of the lesion by Schwann cells reflects the degree of astrocyte damage incurred within the demyelinated area and is greatest for ethidium bromide-induced demyelination. These new models not only provide further insights into the mechanisms of CNS remyelination but also provide a valuable new resource for addressing a series of key issues relevant to current efforts to promote CNS remyelination either by the enhancement of intrinsic processes or by the transplantation of myelinogenic cells.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9932868     DOI: 10.1002/(sici)1098-1136(19990201)25:3<216::aid-glia2>3.0.co;2-l

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   7.452


  100 in total

1.  Differential pathotropism of non-immortalized and immortalized human neural stem cell lines in a focal demyelination model.

Authors:  Daniela Ferrari; Cristina Zalfa; Laura Rota Nodari; Maurizio Gelati; Luigi Carlessi; Domenico Delia; Angelo Luigi Vescovi; Lidia De Filippis
Journal:  Cell Mol Life Sci       Date:  2011-11-11       Impact factor: 9.261

2.  Fast activation of feedforward inhibitory neurons from thalamic input and its relevance to the regulation of spike sequences in the barrel cortex.

Authors:  Fumitaka Kimura; Chiaki Itami; Koji Ikezoe; Hiroshi Tamura; Ichiro Fujita; Yuchio Yanagawa; Kunihiko Obata; Minoru Ohshima
Journal:  J Physiol       Date:  2010-06-07       Impact factor: 5.182

3.  Expression of stathmin, a developmentally controlled cytoskeleton-regulating molecule, in demyelinating disorders.

Authors:  Aixiao Liu; Christine Stadelmann; Mario Moscarello; Wolfgang Bruck; Andre' Sobel; Fabrizio G Mastronardi; Patrizia Casaccia-Bonnefil
Journal:  J Neurosci       Date:  2005-01-19       Impact factor: 6.167

Review 4.  Cell therapy in demyelinating diseases.

Authors:  Claire Rice; Christopher Halfpenny; Neil Scolding
Journal:  NeuroRx       Date:  2004-10

Review 5.  Strategies for achieving and monitoring myelin repair.

Authors:  Claire Rice; Neil Scolding
Journal:  J Neurol       Date:  2007-03-07       Impact factor: 4.849

6.  CNTF promotes the survival and differentiation of adult spinal cord-derived oligodendrocyte precursor cells in vitro but fails to promote remyelination in vivo.

Authors:  Jason F Talbott; Qilin Cao; James Bertram; Michael Nkansah; Richard L Benton; Erin Lavik; Scott R Whittemore
Journal:  Exp Neurol       Date:  2006-12-20       Impact factor: 5.330

7.  Activated cyclic AMP-response element binding protein (CREB) is expressed in a myelin-associated protein in chick.

Authors:  Dong Woon Kim; Jae Hyuk Chang; Sang Wook Park; Gye Sun Jeon; Je Hoon Seo; Sa Sun Cho
Journal:  Neurochem Res       Date:  2005-09       Impact factor: 3.996

8.  Oligoprogenitor cells derived from spermatogonia stem cells improve remyelination in demyelination model.

Authors:  M Nazm Bojnordi; M Movahedin; T Tiraihi; M Javan; H Ghasemi Hamidabadi
Journal:  Mol Biotechnol       Date:  2014-05       Impact factor: 2.695

Review 9.  Current advancements in promoting remyelination in multiple sclerosis.

Authors:  David Kremer; Rainer Akkermann; Patrick Küry; Ranjan Dutta
Journal:  Mult Scler       Date:  2018-10-01       Impact factor: 6.312

Review 10.  Debris clearance by microglia: an essential link between degeneration and regeneration.

Authors:  H Neumann; M R Kotter; R J M Franklin
Journal:  Brain       Date:  2008-06-20       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.